
April 23 (Reuters) - Novavax Inc NVAX.O:
NOVAVAX INC - TO ENGAGE WITH FDA TO ADDRESS PMC REQUEST - SEC FILING
NOVAVAX: "WE BELIEVE THAT OUR BLA IS APPROVABLE BASED ON CONVERSATIONS WITH FDA, AS OF OUR PDUFA DATE ON APRIL 1 AND THROUGH TODAY"
NOVAVAX INC - FDA REQUESTS POST MARKETING COMMITMENT FOR ADDITIONAL CLINICAL DATA FOR ITS COVID-19 VACCINE